$RLMD

2 stories mentioning RLMDUpdated 40d ago

Every FINWIRES story that references RLMD, newest first.

Relmada Therapeutics Joins Russell 2000, Russell 3000 Indexes

Relmada Therapeutics (RLMD) said Monday it joined the Russell 2000 Index and Russell 3000 Index after the US market closed on June 26, as part of the Russell Indexes reconstitution.Shares were over 2% higher in afternoon trading.Price: $6.85, Change: $+0.15, Percent Change: +2.32%

$RLMD

Research51d ago

HC Wainwright Initiates Relmada Therapeutics at Buy With $12 Price Target

Relmada Therapeutics (RLMD) has an average rating of buy and mean price target of $12.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$RLMD

Track with the FINWIRES app suite

FolioX

Track RLMD in your portfolio

WheelAI

Analyze RLMD options with the wheel strategy

StockInsider

See market sentiment on RLMD